期刊文献+

自拟五黄汤结合西药治疗Ⅲ型前列腺炎的临床研究 被引量:2

Clinical Study on Self-made Wuhuang Tang Combined with Western Medicine for Type Ⅲ Prostatitis
原文传递
导出
摘要 目的:探讨中药组方自拟五黄汤治疗Ⅲ型前列腺炎(慢性非细菌性前列腺炎,CNBP)的机制,将中医药治疗的作用机制推进到分子水平。方法:将90例CNBP患者分为2组,每组45例,分别采用西药、中西药结合进行治疗,并对治疗前、后前列腺液常规、白介素-1β(IL-1β)、肿瘤坏死因子(TNF-α)等指标进行统计分析。结果:患者经自拟五黄汤配合西药治疗后的IL-1β、TNF-α水平与西药单独治疗后比较显著下降,临床症状明显改善。结论:自拟五黄汤能明显改善CNBP患者症状,显著降低患者前列腺液中IL-1β、TNF-α水平,是较为有效的治疗CNBP临床经验方。 OBJECTIVE: To study the action mechanism of the self - made Wuhuang tang(Chinese medicine) in the treatment of type Ⅲ prostatitis(chronic nonbacterial prostatitis, CNBP) so as to promote the action mechanism of traditional Chinese medicine to the molecular level. METHODS: 90 patients with CNBP were divided into two groups( n = 45 each): one group received western medicine alone, another group received integrated Chinese and western medicine(ICWM) (Wuhuang tang plus western medicine) . The indicators such as the expressed prostatic secretions(EPS) routine, IL- 1β, and TNF a before and after the treatment were analyzed statistically. RESULTS: The levels of IL 1β and TNF- a in ICWM- treated group decreased significantly and the clinical symptoms of these patients improved significantly as compared with those treated with western medicine alone. CONCLUSION: The self- made Wuhuang tang can markedly alleviate the symptoms of CNBP patients and decrease levels of IL - 1β and TNF - a in patients' EPS, thus it is an effective clinical empirical prescription for CNBP.
出处 《中国药房》 CAS CSCD 北大核心 2009年第30期2383-2384,共2页 China Pharmacy
关键词 五黄汤 慢性非细菌性前列腺炎 细胞因子 Wuhuang tang Chronic nonbacterial prostatitis Cytokine
  • 相关文献

参考文献2

  • 1Orhan I, Onur R, Ilhan N, et al. Seminal plasma cytokines in the diagnosis of chronic pelvic pain syndrome[J ]. Int J Urol,2001,8:495.
  • 2Chroc proststitis workshop.National institutes of health.Bethesda Maryland[J] .Acta Urol Belg, 1995, 41 (1).7.

同被引文献20

  • 1赵海军,韩保健,侯成玉.慢性非细菌性前列腺炎患者前列腺液中TNF-α、IL-10水平变化及意义[J].山东医药,2007,47(21):52-53. 被引量:9
  • 2郭应禄 李宏军.前列腺炎[M].北京:人民军医出版社,2003.79-98.
  • 3国家中医药管理局.中医病症诊断疗效标准[M].南京:南京大学出版社,1994:186.
  • 4Chroc Proststitis workshop. National institutes of health. Bethesda Maryland. Acta Urol Belg, 1995, 41(17:7.
  • 5Krieger JN, Ross SO, Riley DE. Chronic Prostatitis: Epidemiology and role of infection.Urology, 2002, 60(6 Suppl):8- 12.
  • 6Hochreiter WW, Nadler RB, Koch AE, et al. Evaluation of the ey- tokines interleukin 8 and epithelial neutrophil activating Peptide 78 asindieators of inflammation in Prostatic secretions. Urology, 2000, 56(6):1025 - 1029.
  • 7Schaffer AJ, Krieger JN, Curtis N, et al. Overview summary state- ment. Urology, 2002, 606A:1.
  • 8Motrich RD, Maccioni M, Molina R, et al. Presence of IFN gam- ma-secreting lymPhocytes specific to Prostate antigensin a group of chronic Prostatitis Patients. Clin Immunol, 2005, 116(2):149-157.
  • 9郭应禄,李宏军. 前列腺炎 [M]. 北京: 人民军医出版社,2003 ∶374-386.
  • 10Shoskes DA.Use of antibiotics in chronic prostatitis syndromes[J].Can J Urol,2001,8(suppl 1):24-28.

引证文献2

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部